What is the recommended dose of Colistin (polymyxin E) for patients with normal or impaired renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Colistin Dosing Recommendations

All patients should receive a loading dose of 9 million IU (equivalent to 5 mg/kg) of colistin regardless of renal function, followed by maintenance dosing adjusted based on creatinine clearance. 1, 2

Loading Dose (All Patients)

  • Administer 9 million IU (MU) as a loading dose to rapidly achieve therapeutic levels, regardless of renal function status 1, 2
  • This loading dose is critical because colistin has a relatively long half-life in relation to dosing intervals, and therapeutic levels must be achieved quickly 1, 2
  • The loading dose is equivalent to 5 mg/kg of colistin base activity 2

Maintenance Dosing Based on Renal Function

Normal Renal Function (CrCl ≥80 mL/min)

  • Standard maintenance dose: 4.5 million IU every 12 hours (total 9 million IU/day) 1, 2
  • Alternative weight-based dosing: 2.5-5 mg/kg/day divided into 2-4 doses 1, 3
  • For critically ill patients with severe sepsis/septic shock: 4.5 million IU every 12 hours 1

Mild Renal Impairment (CrCl 50-79 mL/min)

  • 2.5-3.8 mg/kg divided into 2 doses per day 3
  • Maintenance dose should be individually adjusted according to creatinine clearance 1

Moderate Renal Impairment (CrCl 30-49 mL/min)

  • 2.5 mg/kg once daily or divided into 2 doses per day 3

Severe Renal Impairment (CrCl 10-29 mL/min)

  • 1.5 mg/kg every 36 hours 3

Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT)

  • Administer at least 9 million IU/day 1, 2
  • Give the normal loading dose of 9 million IU initially 1
  • Consider polymyxin B as an alternative since it doesn't require dose adjustment during CRRT 1, 4

Intermittent Hemodialysis

  • 2 million IU every 12 hours with normal loading dose 1
  • Schedule dialysis toward the end of a colistin dosage interval 1

Continuous Ambulatory Peritoneal Dialysis (CAPD)

  • Loading dose: 300 mg CBA on day 1 5
  • Maintenance: 150-200 mg CBA daily 5
  • CAPD clearance is low for both CMS and colistin, so doses should not be increased 5

Administration Method

  • Administer as a 4-hour infusion to optimize pharmacokinetic/pharmacodynamic properties 1, 2
  • For IV administration, can use direct intermittent injection (over 3-5 minutes) or continuous infusion 3

Critical Dosing Considerations

Important Conversions

  • Colistin is administered as colistimethate sodium (CMS), an inactive prodrug 1, 2, 4
  • 1 million IU of colistin = 80 mg of CMS 1, 2, 4

Dosing in Obesity

  • Base dosing on ideal body weight, not actual body weight 3

Monitoring Requirements

  • Close monitoring of renal function is mandatory during colistin therapy 2
  • Acute kidney injury during and after colistin treatment significantly impacts clinical failure and mortality 2
  • Colistin-associated nephrotoxicity occurs earlier and more frequently than with polymyxin B 4

Common Pitfalls to Avoid

  • Do not skip the loading dose in patients with renal impairment - the loading dose is given regardless of renal function 1, 2
  • Do not use actual body weight in obese patients - this leads to overdosing 3
  • Do not increase doses during CAPD - clearance by CAPD is minimal 5
  • Many patients with renal impairment receive doses not in accordance with recommendations, leading to either subtherapeutic or toxic levels 6
  • The standard 9 MU daily dose may be inadequate for pathogens with MIC ≥1 μg/mL, particularly Pseudomonas species 7, 8

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.